Blood and Marrow Transplantation Long Term Management. Группа авторов
CHAPTER 8: Long‐term follow‐up of children Introduction Common posttransplant screening and prevention guidelines Survivorship care plans References CHAPTER 9: Graft‐versus‐host disease and late effects after hematopoietic stem cell transplantation Introduction cGVHD and nonmalignant late effects Secondary Malignancies References CHAPTER 10: Screening and prevention guidelines for hematopoietic cell transplant survivors Introduction Published guidelines for screening and prevention of late complications in hsct survivors Non‐infectious late effects Infectious and immunologic Subsequent neoplasms Treatment summary and survivorship care plans Areas for future research References CHAPTER 11: Biology of survivorship after blood or marrow transplantation Introduction Anthracycline‐related heart failure Therapy‐related myeloid neoplasia Cognitive outcomes Conclusions References
8 SECTION 2: Specific late effects CHAPTER 12: Second malignancies Introduction Estimating the risk of second cancers Pathophysiology Risk factors for secondary malignancies Diagnosis, screening and prevention Management; Treatment and Recommendations References CHAPTER 13: Anti‐infective prophylaxis, immunization and prevention of late infectious complications Introduction Vaccination Prevention of bacterial infections Prevention of viral infections Prevention of fungal infections References CHAPTER 14: Seasonal respiratory viral infections Introduction Community Respiratory Virus Infections in HCT Recipients Respiratory viruses and alloimmune lung syndrome Diagnostic Evaluation Treatment Options Preventing exposure Preventing Disease and Progression to LRTI Future Considerations References CHAPTER 15: Monitoring and management of hepatitis B, C, and HIV infection before and after transplantation Hepatitis B Virus (HBV) Hepatitis C Virus (HCV) Human Immunodeficiency Virus (HIV) Acknowledgment References CHAPTER 16: Skin chronic GVHD Introduction cGVHD pathophyisiology Pathological findings in cutaneous cGVHD Clinical manifestations Clinical management Imaging and instrumental tools in skin cGVHD Systemic treatment Ancillary and topical treatment References CHAPTER 17: Ocular complications Introduction Ocular graft‐versus‐host disease Cataract formation Other non‐GVHD ocular complications Recommendations for the survivors / general practitioner References CHAPTER 18: Management of oral and dental complications